Zsa Zsa Weerts

Novel ileocolonic release peppermint oil 137 6 receptor potential channel TRPA1. J Neurosci 2007;27:9874-9884. 46. Yoshida N, Naito Y, Hirose R, et al. Prevention of colonic spasm using L-menthol in colonoscopic examination. Int J Colorectal Dis 2014;29:579-583. 47. Asao T, Mochiki E, Suzuki H, et al. An easy method for the intraluminal administration of peppermint oil before colonoscopy and its effectiveness in reducing colonic spasm. Gastrointest Endosc 2001;53:172-177. 48. Inoue K, Dohi O, Gen Y, et al. L-menthol improves adenoma detection rate during colonoscopy: a randomized trial. Endoscopy 2014;46:196-202. 49. Nair B. Final report on the safety assessment of Mentha Piperita (Peppermint) Oil, Mentha Piperita (Peppermint) Leaf Extract, Mentha Piperita (Peppermint) Leaf, and Mentha Piperita (Peppermint) Leaf Water. Int J Toxicol 2001;20 Suppl 3:61-73. 50. Heimes K, Hauk F, Verspohl EJ. Mode of action of peppermint oil and (-)-menthol with respect to 5-HT3 receptor subtypes: binding studies, cation uptake by receptor channels and contraction of isolated rat ileum. Phytother Res 2011;25:702-708. 51. European Medicines Agency (EMA). Public Statement on the use of herbal medicinal products containing pulegone and menthofuran. 2016. 52. European Medicines Agency, Committee on herbal medicinal products (HMPC) Community Herbal Monopgraph on Mentha x Piperita L, Artheroleum. EMEA/HMPC/ 349466/2006. 2007. 53. Lovell R, Ford A. Global prevalence of and risk factors for irritable bowel syndrome: a meta- analysis. Clin Gastroenterol Hepatol 2012;10: 712-721 e714. 54. Schwartz JB. The influence of sex on pharmacokinetics. Clin Pharmacokinet 2003; 42:107-121.